| scholarly article | Q13442814 |
| P2093 | author name string | Chantal Matar | |
| Ismail Fliss | |||
| Jason Leblanc | |||
| P2860 | cites work | Diarrheagenic Escherichia coli | Q24533466 |
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Epithelial M cells: differentiation and function | Q28141133 | ||
| Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins | Q29547534 | ||
| Accumulation of casein-derived peptides during growth of proteinase-positive strains of Lactococcus lactis in milk: their contribution to subsequent bacterial growth is impaired by their internal transport | Q31391721 | ||
| Clinical presentation, complications and treatment of infection with verocytotoxin-producing Escherichia coli. Challenges for the clinician | Q33333028 | ||
| Antibodies to lipopolysaccharide block adherence of Shiga toxin-producing Escherichia coli to human intestinal epithelial (Henle 407) cells | Q33501646 | ||
| Human response to Escherichia coli O157:H7 infection: antibodies to secreted virulence factors | Q33598843 | ||
| Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties | Q33757977 | ||
| The B-cell system of human mucosae and exocrine glands | Q33784957 | ||
| Regulation of the formation and external transport of secretory immunoglobulins. | Q33824583 | ||
| Collaboration of epithelial cells with organized mucosal lymphoid tissues. | Q33955758 | ||
| Bioactive milk peptides: a prospectus | Q33956865 | ||
| The public health significance of VTEC O157. | Q33958106 | ||
| VTEC enteropathogenicity | Q33958112 | ||
| Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits | Q34006082 | ||
| Effects of milk-derived bioactives: an overview. | Q34176970 | ||
| Immunomodulatory properties of milk | Q34177045 | ||
| Immunoregulatory peptides in bovine milk. | Q34177070 | ||
| Hemorrhagic Colitis Associated with a RareEscherichia coliSerotype | Q34256166 | ||
| Immunomodulatory effects of dietary whey proteins in mice | Q34299236 | ||
| Lactic acid bacteria and their effect on the immune system | Q34440272 | ||
| Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. | Q34546569 | ||
| Current understanding of gastrointestinal immunoregulation and its relation to food allergy | Q34649134 | ||
| Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. | Q35208385 | ||
| Implication of virulence factors in Escherichia coil O157:H7 pathogenesis | Q35592357 | ||
| Colonization resistance of the digestive tract in conventional and antibiotic-treated mice | Q36252753 | ||
| Biologically active peptides in milk proteins | Q38762261 | ||
| Immune System Stimulation by Probiotics | Q40434311 | ||
| Prevention of Salmonella typhimurium infection inpoultry by pretreatment of chickens and poults with intestinal extracts | Q40770928 | ||
| Antigen sampling across epithelial barriers and induction of mucosal immune responses | Q41039707 | ||
| Oral tolerance: immune mechanisms and treatment of autoimmune diseases | Q41546336 | ||
| Intimin type influences the site of human intestinal mucosal colonisation by enterohaemorrhagic Escherichia coli O157:H7. | Q41879042 | ||
| Enterohaemorrhagic Escherichia coli O157:H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine | Q43086295 | ||
| Suppression of T-cell activation by Lactobacillus rhamnosus GG-degraded bovine casein | Q43613350 | ||
| Inhibitory activity of Bifidobacterium longum HY8001 against Vero cytotoxin of Escherichia coli O157:H7. | Q43810790 | ||
| Antagonistic activity of Lactobacillus casei strain shirota against gastrointestinal Listeria monocytogenes infection in rats | Q43910008 | ||
| Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus | Q44252719 | ||
| Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains | Q44851597 | ||
| Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake | Q45008188 | ||
| Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001. | Q50111254 | ||
| Immunoadjuvant activity of oralLactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections | Q50183975 | ||
| Prevention of gastrointestinal infection using immunobiological methods with milk fermented with Lactobacillus casei and Lactobacillus acidophilus | Q50465344 | ||
| Lactobacillus helveticus heterogeneity in natural cheese starters: the diversity in phenotypic characteristics. | Q53891470 | ||
| Susceptibility of three strains of conventional adult mice to intestinal colonization by an isolate of Escherichia coli O157:H7. | Q54115291 | ||
| Protein degradation by human intestinal bacteria | Q68929525 | ||
| Biologically active casein peptides implicated in immunomodulation | Q69522676 | ||
| Down-regulation of anti-CD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes | Q71134449 | ||
| Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes | Q71423342 | ||
| Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG | Q71512642 | ||
| The effect of milk fermentation by Lactobacillus helveticus on the release of peptides during in vitro digestion | Q71580976 | ||
| Immunomodulatory activity of beta-casein permeate medium fermented by lactic acid bacteria | Q73064982 | ||
| Effect of dietary whey protein concentrate on primary and secondary antibody responses in immunized BALB/c mice | Q73133641 | ||
| Gut mucosal immunostimulation by lactic acid bacteria | Q73496465 | ||
| Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice | Q74710309 | ||
| Probiotics reinforce mucosal degradation of antigens in rats: implications for therapeutic use of probiotics | Q77734015 | ||
| M cells in antigen sampling in mucosal tissues | Q77808322 | ||
| Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant | Q77866382 | ||
| Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria | Q77935482 | ||
| Interaction of lactic acid bacteria with the gut immune system | Q78853845 | ||
| P433 | issue | 6 | |
| P921 | main subject | Escherichia coli | Q25419 |
| Lactobacillus helveticus | Q142378 | ||
| P304 | page(s) | 1171-1181 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Induction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus-fermented milk | |
| P478 | volume | 11 |
| Q41868227 | Bacterial cinnamoyl esterase activity screening for the production of a novel functional food product. |
| Q42138165 | Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge |
| Q26745047 | Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines |
| Q49943314 | Biological activity of the non-microbial fraction of kefir: antagonism against intestinal pathogens |
| Q43144967 | Biopeptides and immune exclusion |
| Q21245683 | Bovine milk in human nutrition--a review |
| Q39751453 | Characterization of immune-active peptides obtained from milk fermented by Lactobacillus helveticus |
| Q36502198 | Chitosan-Based Intranasal Vaccine against Escherichia coli O157:H7. |
| Q38128618 | Commensal Clostridia: leading players in the maintenance of gut homeostasis. |
| Q38491157 | Effect of Lactobacillus brevis KB290 on the cell-mediated cytotoxic activity of mouse splenocytes: a DNA microarray analysis |
| Q33343715 | Effect of the administration of a fermented milk containing Lactobacillus casei DN-114001 on intestinal microbiota and gut associated immune cells of nursing mice and after weaning until immune maturity |
| Q34550242 | Effects of the probiotic Lactobacillus animalis in murine Mycobacterium avium subspecies paratuberculosis infection |
| Q38287036 | Food derived bioactive peptides and intestinal barrier function. |
| Q36407339 | Health-Promoting Properties of Lactobacillus helveticus. |
| Q90246645 | Immunomodulatory Protein Hydrolysates and Their Application |
| Q34232929 | Immunomodulatory effect of non-viable components of probiotic culture stimulated with heat-inactivated Escherichia coli and Bacillus cereus on holoxenic mice. |
| Q55304046 | Lactobacillus frumenti Facilitates Intestinal Epithelial Barrier Function Maintenance in Early-Weaned Piglets. |
| Q36655465 | Lactobacillus helveticus: the proteolytic system |
| Q55515209 | Milk Fermented by Specific Lactobacillus Strains Regulates the Serum Levels of IL-6, TNF-α and IL-10 Cytokines in a LPS-Stimulated Murine Model. |
| Q41782959 | Milk fermentation products of L. helveticus R389 activate calcineurin as a signal to promote gut mucosal immunity |
| Q38049200 | Modern approaches in probiotics research to control foodborne pathogens. |
| Q34497115 | Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection |
| Q33412526 | Oral administration of Shiga toxin-producing Escherichia coli induces intestinal and systemic specific immune response in mice |
| Q54431643 | Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli DeltatolR IHE3034 mutant. |
| Q41402058 | Technological and probiotic potential of BGRA43 a natural isolate of Lactobacillus helveticus. |
| Q92712348 | The protective effects of enriched citrulline fermented milk with Lactobacillus helveticus on the intestinal epithelium integrity against Escherichia coli infection |
Search more.